607 related articles for article (PubMed ID: 25444473)
1. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
Miura JT; Gamblin TC
Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
[TBL] [Abstract][Full Text] [Related]
2. Transarterial approaches to primary and secondary hepatic malignancies.
Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
Nat Rev Clin Oncol; 2015 Aug; 12(8):481-9. PubMed ID: 25985939
[TBL] [Abstract][Full Text] [Related]
3. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.
Xing M; Kooby DA; El-Rayes BF; Kokabi N; Camacho JC; Kim HS
J Surg Oncol; 2014 Aug; 110(2):182-96. PubMed ID: 24760444
[TBL] [Abstract][Full Text] [Related]
4. Chemoembolization of hepatic malignancy.
Gonsalves CF; Brown DB
Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
Fidelman N; Kerlan RK
AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
Tsochatzis EA; Germani G; Burroughs AK
Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
Iozzino M; Spaziani E; Picchio M; Saltarelli A; Di Filippo A; De Angelis F; Narilli F; Stagnitti F; Cianni R
Clin Ter; 2011; 162(2):129-32. PubMed ID: 21533319
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.
Lee EW; Khan S
Clin Mol Hepatol; 2017 Dec; 23(4):265-272. PubMed ID: 29113030
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter treatment of hepatic metastases.
Pentecost MJ
AJR Am J Roentgenol; 1993 Jun; 160(6):1171-5. PubMed ID: 8388617
[TBL] [Abstract][Full Text] [Related]
10. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
[TBL] [Abstract][Full Text] [Related]
11. Transarterial therapies for primary liver tumors.
Talenfeld AD; Sista AK; Madoff DC
Surg Oncol Clin N Am; 2014 Apr; 23(2):323-51. PubMed ID: 24560113
[TBL] [Abstract][Full Text] [Related]
12. Chemoembolization of hepatic malignancies.
Soulen MC
Oncology (Williston Park); 1994 Apr; 8(4):77-84; discussion 84, 89-90 passim. PubMed ID: 8003400
[TBL] [Abstract][Full Text] [Related]
13. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
Gannon CJ; Curley SA
Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
[TBL] [Abstract][Full Text] [Related]
14. [Chemoembolization and ethanol ablation of primary hepatic carcinoma and metastatic tumors].
Rudzki S; Jamroz A
Pol Merkur Lekarski; 2004 Jan; 16(91):78-81. PubMed ID: 15074029
[TBL] [Abstract][Full Text] [Related]
15. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline.
Karanicolas P; Beecroft JR; Cosby R; David E; Kalyvas M; Kennedy E; Sapisochin G; Wong R; Zbuk K;
Clin Colorectal Cancer; 2021 Mar; 20(1):20-28. PubMed ID: 33257278
[TBL] [Abstract][Full Text] [Related]
16. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
17. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
[TBL] [Abstract][Full Text] [Related]
19. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.
Shin JU; Kim KM; Shin SW; Min SY; Park SU; Sinn DH; Gwak GY; Choi MS; Lee JH; Paik SW; Yoo BC; Koh KC
Dig Liver Dis; 2014 Sep; 46(9):813-7. PubMed ID: 24881853
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]